Search This Blog

Tuesday, June 23, 2026

AbbVie hep C win may expand Enanta’s royalty revenue from the MAVIRET regimen

 

AbbVie wins European Commission approval for MAVIRET to treat acute hepatitis C in adults and children

  • Approval for acute hepatitis C in adults and children may expand Enanta’s royalty revenue from the MAVIRET regimen.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)